• LAST PRICE
    0.2865
  • TODAY'S CHANGE (%)
    Trending Up0.0064 (2.2849%)
  • Bid / Lots
    0.2864/ 1
  • Ask / Lots
    0.2865/ 1
  • Open / Previous Close
    0.3000 / 0.2801
  • Day Range
    Low 0.2828
    High 0.3000
  • 52 Week Range
    Low 0.1990
    High 9.7050
  • Volume
    63,526
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.2801
TimeVolumeAMPE
09:32 ET7350.3
09:39 ET15820.29
09:44 ET2480.2901
09:48 ET1000.2944
09:50 ET8490.29225
09:53 ET5090.2944
09:55 ET1000.2943
10:02 ET1000.29205
10:08 ET4850.2921
10:20 ET10000.29275
10:27 ET13430.2928
10:33 ET54350.292
10:44 ET120040.2915
10:47 ET1340.2922
10:56 ET4680.2922
11:05 ET5000.2943
11:09 ET9670.294
11:14 ET1000.2902
11:34 ET1000.2937
11:43 ET2000.293699
11:45 ET2000.2937
11:48 ET4170.293
11:50 ET6780.293
11:54 ET2680.2931
11:56 ET2000.294
11:57 ET1950.2944
11:59 ET7300.2944
12:08 ET1070.293001
12:17 ET1400.295
12:19 ET3220.295
12:24 ET1390.2926
12:32 ET1870.2923
12:37 ET14450.29365
12:39 ET10000.2923
12:50 ET52000.2907
12:57 ET138370.2908
01:00 ET26940.2828
01:09 ET35190.2855
01:13 ET5000.2899
01:20 ET10000.29
01:38 ET14450.2865
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAMPE
Ampio Pharmaceuticals Inc
4.2M
-0.2x
---
United StatesPALI
Palisade Bio Inc
4.2M
-0.2x
---
United StatesLADX
LadRx Corp
4.0M
-0.3x
---
United StatesKRBP
Kiromic Biopharma Inc
3.9M
-0.1x
---
United StatesTENX
Tenax Therapeutics Inc
3.9M
-5.8x
---
United StatesFNAM
Evolutionary Genomics Inc
4.7M
-1.7x
---
As of 2023-02-02

Company Information

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company that is focused on the research, development, and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. The Company's lead product candidate, Ampion has immunomodulatory action and anti-inflammatory effects, which provide a treatment for individuals with inflammatory conditions including, but not limited to, severe osteoarthritis of the knee (OAK); osteoarthritis related to other joints, such as hip, shoulder, ankle and hand; and the widespread inflammation associated with COVID-19 infection. Ampion is in development as an intra-articular injection treatment for severe OAK, an intravenous (IV) and inhaled treatment for hospitalized severe and/or critical COVID-19 patients, and an at-home inhalation treatment for patients with prolonged respiratory symptoms due to COVID-19, referred to as Long-COVID. Its clinical studies include AP-013, AP-017, AP-019 and AP-018.

Contact Information

Headquarters
373 Inverness Parkway, Suite 200ENGLEWOOD, CO, United States 80112
Phone
720-437-6500
Fax
720-437-6501

Executives

Independent Chairman of the Board
J. Kevin Buchi
Chief Executive Officer, Director
Michael Martino
Chief Financial Officer, Secretary
Daniel Stokely
Independent Director
Elizabeth Jobes
Independent Director
David Stevens

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.2M
Revenue (TTM)
$0.00
Shares Outstanding
15.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.70
EPS
$-1.39
Book Value
$1.80
P/E Ratio
-0.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.